查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553644

兒科心臟腫瘤診斷市場規模、佔有率、趨勢分析報告：按腫瘤、類型、最終用途、地區、細分市場預測，2024-2030 年

Pediatric Cardiac Tumor Diagnostic Market Size, Share & Trend Analysis Report By Tumor (Primary Cardiac Tumors, Secondary Cardiac Tumors), By Type (Echocardiography, MRI), By End-use, By Region, and Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10個工作天內

價格

兒科心臟腫瘤診斷市場的成長和趨勢：

Grand View Research, Inc.最新報告預測，到2030年，全球兒科心臟腫瘤診斷市場規模預計將達到10.6億美元，2024年至2030年複合年成長率為8.03%。

該市場的成長歸功於醫療技術的不斷提高和進步。隨著兒童先天性心臟疾病和腫瘤的增加，對準確、早期診斷工具的需求迅速增加。先進的影像技術和改進的生物標記等技術創新提高了診斷能力，可以更早檢測和更好地管理兒童心臟腫瘤。例如，2021 年 6 月，西班牙國家循環系統研究中心和飛利浦合作開發了一種用於研究目的的超快心臟 MRI通訊協定。該合作夥伴關係旨在增強未來的臨床功能，包括腫瘤學研究的進展。隨著醫療保健提供者尋求更有效的解決方案來診斷和治療這些罕見疾病，此類創新可以改善患者的治療效果並推動市場成長。

此外，技術進步對兒科心臟腫瘤診斷市場產生重大影響並推動其成長。高解析度 MRI 和電腦斷層掃描技術的發展使得以更高的精度和細節對兒童心臟腫瘤進行成像成為可能。這些影像方式增強了早期發現和準確診斷，對於有效治療至關重要。此外，將人工智慧 (AI) 整合到診斷過程中，透過分析複雜的影像資料進一步提高準確性和效率。隨著這些技術的發展，透過提供更好的診斷工具、改善患者的治療效果以及降低與兒科心臟腫瘤治療相關的醫療保健成本，預計市場成長將會擴大。

對兒科醫療保健的投資和對腫瘤學研究的資助是推動市場成長的關鍵因素。增加對兒科醫療保健的投資將確保先進診斷工具和技術的發展，例如高解析度 MRI 和電腦斷層掃描，這對於準確檢測和監測兒童心臟腫瘤至關重要。例如，2024 年 6 月，亞馬遜網路服務公司投資 1,000 萬美元來推進兒科醫學研究並增進對包括腫瘤在內的罕見疾病的了解。這些投資不僅將加速技術進步，還將透過增加創新診斷解決方案的可用性來提高醫療保健品質並擴大市場。

此外，公眾和專業人士對兒科癌症護理了解的提高將增加對先進診斷工具和早期檢測方法的需求。例如，國際兒童癌症日是一項全球計劃，旨在提高對兒童癌症的認知，並向受影響的兒童、青少年、倖存者及其家人表示支持。隨著意識的提高，專業影像技術和治療的市場也在擴大，從而導致該領域的投資和創新增加。人們對兒科醫學日益成長的興趣將支持市場擴張並改善患有心臟腫瘤的兒童的治療結果。

兒科心臟腫瘤診斷市場報告亮點

  • 由於影像技術的進步、認知的提高和診斷工具的改進，原發性心臟腫瘤部分在 2023 年佔據最大佔有率，為 84.81%。這些因素有利於早期發現和治療，進而促進市場擴張。
  • 超音波心動圖領域因其非侵入性、先進的成像能力以及提高的診斷準確性，在2023年佔據最大佔有率，達到60.76%。飛利浦和通用電氣醫療保健等主要企業正在利用先進技術推動創新，以改善早期檢測和治療結果。
  • 到2023年，在醫療基礎設施改善、資金籌措和投資增加的推動下，醫院和診所部門將佔據最大佔有率，達到73.89%。增強的設施和資源支持先進的診斷技術，從而更好地檢測和管理小兒心臟腫瘤。
  • 北美地區主導全球兒科心臟腫瘤診斷市場，2023年佔36.44%的銷售佔有率。包括先進成像技術和研究在內的策略開拓和創新正在推動該地區的市場成長並提高診斷準確性。
  • 兒科心臟腫瘤診斷市場競爭激烈，主要企業佔有重要地位。主要企業正在採取各種策略，包括新產品開發、收購、聯盟、併購和區域擴張，以滿足客戶未滿足的需求。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章兒科心臟腫瘤診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 兒科心臟腫瘤診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章小兒心臟腫瘤診斷市場：依腫瘤類型估計及趨勢分析

  • 細分儀表板
  • 兒科心臟腫瘤診斷市場：腫瘤變化分析
  • 按腫瘤分類的展望：兒科心臟腫瘤診斷市場
  • 2018-2030年市場規模、預測及趨勢分析
  • 原發性心臟腫瘤
  • 續發性心臟腫瘤

第5章兒科心臟腫瘤診斷市場：按類型估計和趨勢分析

  • 細分儀表板
  • 兒科心臟腫瘤診斷市場：類型變異分析
  • 兒科心臟腫瘤診斷市場：按類型分類的展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 心臟超音波圖
  • 磁振造影(MRI)
  • 電腦斷層掃描 (CT) 掃描
  • 其他

第6章兒科心臟腫瘤診斷市場：最終用途的估計和趨勢分析

  • 細分儀表板
  • 兒科心臟腫瘤診斷市場：最終用途變化分析
  • 兒科心臟腫瘤診斷市場：最終用途展望
  • 2018-2030年市場規模、預測及趨勢分析
  • 醫院和診所
  • 衛生署、政府
  • 其他

第7章兒科心臟腫瘤診斷市場：區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • GE HealthCare
    • Siemens Healthineers AG
    • CANON MEDICAL SYSTEMS CORPORATION
    • Boston Scientific Corporation
    • Lantheus
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd
    • Medtronic
Product Code: GVR-4-68040-434-5

Pediatric Cardiac Tumor Diagnostic Market Growth & Trends:

The global pediatric cardiac tumor diagnostic market size is anticipated to reach USD 1.06 billion by 2030 and is projected to grow at a CAGR of 8.03% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to the increasing awareness and advancements in medical technology. With the rise in the prevalence of congenital heart conditions and tumors among children, the demand for accurate and early diagnostic tools has surged. Technological innovations, such as advanced imaging techniques and improved biomarkers, have enhanced diagnostic capabilities, allowing for earlier detection and better management of pediatric cardiac tumors. For instance, in June 2021, the Spanish National Center for Cardiovascular Research and Philips teamed up to develop an ultra-fast cardiac MRI protocol for research purposes. This collaboration aims to enhance clinical practice in the future, including advancements in oncology research. These innovations improve patient outcomes and drive market growth as healthcare providers seek more effective solutions for diagnosing and treating these rare conditions.

Moreover, technological advancements significantly impact the market for pediatric cardiac tumor diagnostics, driving its growth. The development of high-resolution MRI and CT scan technologies allows for more accurate and detailed imaging of cardiac tumors in children. These imaging modalities enhance early detection and precise diagnosis, which are crucial for effective treatment. In addition, the integration of artificial intelligence (AI) into diagnostic processes is further improving accuracy and efficiency by analyzing complex imaging data.As these technologies evolve, they are expected to expand market growth by providing better diagnostic tools, improving patient outcomes, and reducing healthcare costs associated with pediatric cardiac tumor care.

The investment in pediatric care and funding for oncology research are pivotal factors driving the growth of the market. Increased investment in pediatric healthcare ensures the development of advanced diagnostic tools and technologies, such as high-resolution MRI and CT scans, which are crucial for accurately detecting and monitoring cardiac tumors in children. For instance,in June 2024, Amazon Web Services Inc. invested USD 10 million to advance research in pediatric healthcare and enhance the understanding of rare diseases, including tumors. These investments not only accelerate technological advancements but also expand the market by improving the quality of care and increasing the availability of innovative diagnostic solutions.

Furthermore, increased public and professional understanding of pediatric oncology care drives demand for advanced diagnostic tools and early detection methods. For instance, International Childhood Cancer Day is a worldwide initiative aimed at raising awareness about childhood cancer and showing support for affected children, adolescents, survivors, and their families. As awareness grows, so does the market for specialized imaging technologies and treatments, leading to more investment and innovation in this field. This heightened focus on pediatric care supports market expansion and improves outcomes for children with cardiac tumors.

Pediatric Cardiac Tumor Diagnostic Market Report Highlights:

  • The primary cardiac tumors segment held the largest share, 84.81%, in 2023due to advancements in imaging technologies, increased awareness, and improved diagnostic tools. These factors enhance early detection and treatment, driving market expansion.
  • The echocardiography segment held the largest share, 60.76%, in 2023 due to its noninvasive nature, advanced imaging capabilities, and enhanced diagnostic accuracy. Key players like Philips and GE Healthcare drive innovation with advanced technology, improving early detection and treatment outcomes.
  • The hospitals and clinics segment held the largest share, 73.89%, in 2023, fueledby improved healthcare infrastructure, increased funding, and investment. Enhanced facilities and resources support advanced diagnostic technologies, leading to better detection and management of pediatric cardiac tumors.
  • The North America region dominated the overall global market for pediatric cardiac tumor diagnosticsand accounted for the 36.44% revenue share in 2023. Strategic development and innovation, including advanced imaging technologies and research, drive market growth and enhance diagnostic accuracy in this region.
  • The competitive scenario in the pediatric cardiac tumor diagnostic market is high, with key players holding significant positions. The major companies are undertaking various strategies, such as new product development, acquisitions, collaborations, mergers, and regional expansion, to serve their customers' unmet needs.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Tumor
    • 1.2.2. Type
    • 1.2.3. End use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Tumor outlook
    • 2.2.2. Type outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Pediatric Cardiac Tumor Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Pediatric Cardiac Tumor Diagnostic Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Pediatric Cardiac Tumor Diagnostic Market: Tumor Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pediatric Cardiac Tumor Diagnostic Market: Tumor Movement Analysis
  • 4.3. Pediatric Cardiac Tumor Diagnostic Market by Tumor Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Primary Cardiac Tumors
    • 4.5.1. Primary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Secondary Cardiac Tumors
      • 4.5.2.1. Secondary Cardiac Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pediatric Cardiac Tumor Diagnostic Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pediatric Cardiac Tumor Diagnostic Market: Type Movement Analysis
  • 5.3. Pediatric Cardiac Tumor Diagnostic Market by Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Echocardiography
    • 5.5.1. Echocardiography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Magnetic Resonance Imaging (MRI)
    • 5.6.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Computed Tomography (CT) Scan
    • 5.7.1. Computed Tomography (CT) Scan Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pediatric Cardiac Tumor Diagnostic Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pediatric Cardiac Tumor Diagnostic Market: End Use Movement Analysis
  • 6.3. Pediatric Cardiac Tumor Diagnostic Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals and Clinics
    • 6.5.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Government Health Department
    • 6.6.1. Government Health Department Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pediatric Cardiac Tumor Diagnostic Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. GE HealthCare
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Siemens Healthineers AG
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. CANON MEDICAL SYSTEMS CORPORATION
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Boston Scientific Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Lantheus
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Bio-Rad Laboratories, Inc.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Abbott
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. F. Hoffmann-La Roche Ltd
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Medtronic
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 4. Global pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 5. Global pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 6. North America pediatric cardiac tumor diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 7. North America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 8. North America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 9. North America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 10. U.S. pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 11. U.S. pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 12. U.S. pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 13. Canada pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 14. Canada pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 15. Canada pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Mexico pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 17. Mexico pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 18. Mexico pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 19. Europe pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 20. Europe pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 21. Europe pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 22. Europe pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 23. UK pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 24. UK pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 25. UK pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 26. Germany pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 27. Germany pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 28. Germany pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 29. France pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 30. France pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 31. France pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 32. Italy pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 33. Italy pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 34. Italy pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 35. Spain pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 36. Spain pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 37. Spain pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 38. Denmark pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 39. Denmark pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 40. Denmark pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 41. Norway pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 42. Norway pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 43. Norway pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Sweden pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 45. Sweden pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 46. Sweden pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 47. Asia Pacific pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 48. Asia Pacific pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 49. Asia Pacific pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 50. Asia Pacific pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Japan pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 52. Japan pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 53. Japan pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 54. China pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 55. China pediatric cardiac tumor diagnostic market, by type 2018 - 2030 (USD Million)
  • Table 56. China pediatric cardiac tumor diagnostic market, by end use 2018 - 2030 (USD Million)
  • Table 57. India pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 58. India pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 59. India pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Australia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 61. Australia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 62. Australia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 63. South Korea pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 64. South Korea pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 65. South Korea pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 66. Thailand pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 67. Thailand pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 68. Thailand pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 69. Latin America pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 70. Latin America pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 71. Latin America pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 72. Latin America pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 73. Brazil pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 74. Brazil pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 75. Brazil pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 76. Argentina pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 77. Argentina pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 78. Argentina pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 79. Middle East & Africa pediatric cardiac tumor diagnostic market, by country, 2018 - 2030 (USD Million)
  • Table 80. Middle East & Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 81. Middle East & Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 82. Middle East & Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 83. South Africa pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 84. South Africa pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 85. South Africa pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 86. Saudi Arabia pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 87. Saudi Arabia pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 88. Saudi Arabia pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 89. UAE pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 90. UAE pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 91. UAE pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)
  • Table 92. Kuwait pediatric cardiac tumor diagnostic market, by tumor, 2018 - 2030 (USD Million)
  • Table 93. Kuwait pediatric cardiac tumor diagnostic market, by type, 2018 - 2030 (USD Million)
  • Table 94. Kuwait pediatric cardiac tumor diagnostic market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Pediatric cardiac tumor diagnostic market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Pediatric cardiac tumor diagnostic market, tumor outlook key takeaways (USD Million)
  • Fig. 12 Pediatric cardiac tumor diagnostic market: tumor movement analysis (USD Million), 2023 & 2030
  • Fig. 13 Primary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Secondary cardiac tumors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Pediatric cardiac tumor diagnostic market, type outlook key takeaways (USD Million)
  • Fig. 16 Pediatric cardiac tumor diagnostic market: type movement analysis (USD Million), 2023 & 2030
  • Fig. 17 Echocardiography market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Magnetic Resonance Imaging (MRI) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Computed Tomography (CT) scan market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pediatric cardiac tumor diagnostic market, end use outlook key takeaways (USD Million)
  • Fig. 22 Pediatric cardiac tumor diagnostic market: end use movement analysis (USD Million), 2023 & 2030
  • Fig. 23 Hospitals and clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Government health department market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Pediatric cardiac tumor diagnostic market: regional key takeaways (USD Million)
  • Fig. 27 Pediatric cardiac tumor diagnostic market: regional outlook, 2023 & 2030, USD Million
  • Fig. 28 North America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Mexico pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Germany pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 France pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Italy pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Sweden pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Asia Pacific pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Japan pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 India pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Australia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait pediatric cardiac tumor diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 List of key emerging company's/type disruptors/innovators